Pharmacovigilance quality assurance of pharmaceutical management in healthcare
- Slides: 23
Pharmacovigilance – quality assurance of pharmaceutical management in healthcare Sten Olsson WHO Programme Expert Uppsala Monitoring Centre Sweden
Pharmaceuticals Among the most important health interventions in any healthcare system
Getting value for money Medicines Healthcare professionals Healthcare delivery system • Efficacious • Good quality • Safe • Competent • Dedicated • Quality conscious • Well managed • Effective, safe processes
Measuring lack of performance Medicines If suboptimal • Efficacious • Good quality • Safe Lack of effect or toxicity Adverse reactions
Measuring lack of performance Healthcare professionals • Competent • Dedicated • Quality conscious If suboptimal Lack of effect Adverse reactions Medication errors
Measuring lack of performance Healthcare delivery system • Well managed • Effective, safe processes If suboptimal Lack of effect Adverse reactions Medication errors
Pharmacovigilance WHO definition The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems The importance of pharmacovigilance, WHO, 2002
Pharmacovigilance Adverse Reactions • Properties of drug and patient • Pharmacologic • Hypersensitivity • Other Unexpected lack of effect • Inadequate quality • Failing GMP, distribution, storage etc. • SSFFC • Antimicrobial resistance • Inadequate use Medication errors • Inadequate use • Human factors • Failing health systems
We get very few reports of medicine related harm from healthcare – does it show that we have a high-quality healthcare system? No, not necessarily • All medicines have adverse reactions • All human beings make mistakes • All systems fail occasionally
European Union 5% • Hospital admissions due to ADR 5% • Hospitalized patients suffering an ADR 5 th • Most common cause of death 197 000 • Deaths per year € 79 billion • Cost to society /year Ref. Report to European Commission Sept 2008
2012 • 2% of outpatients had preventable ADRs • 52% of ADRs were preventable • 1. 6% of inpatients had preventable ADRs • 45% of ADRs were preventable
If we don’t find adverse reactions, medication errors or unexpected lack of effect It just means that we are not looking well enough We are not vigilant Our pharmacovigilance system is not working
High-quality healthcare delivery systems • Encourage reporting of ADRs, errors and unexpected lack of effect • Is non-punitive • Analyse underlying reasons (root-cause) • Learn from mistakes • Provides feed-back for continous improvement of practices • Prevent harm to future patients
Good models exist Sultan Qaboos University Hospital Muscat, Oman Aqeela Taqi Lawati & Nibu Nair
Examples from Sultanate of Oman Number of ADR reports/million inhab/year 2007 – 2012 as reported to WHO/Vigi. Base™ Contribution from Sultan Qaboos University Hospital
Support from WHO
Why pharmacovigilance indicators? • Measure status of pharmacovigilance system • Able to identify strengths, weaknesses, achievments, growth, impact • Return on investments in PV
Classification • Structure – qualitative - yes/no • Process • Output/impact • Specific indicators for Public Health Programmes
Core structural indicators Existance of : 1. A PV centre with a standard accommodation? 2. A statutory provision for PV? (legislation, policy) 3. A Drug Regulatory Authority/Agency 4. A regular financial provision for the PV centre? 5. Human resources to carry out its functions properly? 6. A standard ADR reporting form? – 7. 8. 9. 10. 4 subset indicators A process in place for collection, recording and analysis of ADRs? Is PV included in national curriculum of schools for health care professionals? A newsletter/information bulletin/website for PV information dissemination? A national ADR or PV advisory committee or expert committee in the setting?
Core process indicators (Tot 9) 1. 2. 3. 4. 5. Total number of ADR reports received last calender year Total number of reports in national/local database Percentage of total annual reports acknowledged Percentage of reports subjected to causality assessment in the year Percentage of national reports satisfactorily completed and submitted to NC last year a) Submitted to WHO 6. Percentage of reports on therapeutic ineffectiveness 7. Percentage of reports on medication errors 8 Percentage of registered MAH having functional PV system 9 No of active surveillance activities initiated, ongoing or completed the last 5 years
Core outcome/impact indicators 1. 2. 3. 4. 5. 6. 7. 8. No of signals identified by PV centre the last 5 years No of regulatory actions taken last year based on national data – Label change – Safety warning – Medicine suspension/withdrawal/other restrictions Number of medicine related hospital admissions/1000 admissions No of medicine related deaths/1000 persons served by hospital No of medicine related deaths/ 100 000 in the population Average cost of treatment of medicine-related illness Average duration of extension of medicine-related hospital stay Average cost of medicine related hospitalization
Conclusion Pharmacovigilance is the system by which the pharmaceutical management in any healthcare setting is being quality assured Through pharmacovigilance indicators the appropriateness of the pharmacovigilance system can be measured The ultimate goal is to minimize the occurrence of preventable medicine-related harm to patients
Thank you for your attention! info@who-umc. org www. who-umc. org
- Pharmacovigilance quality assurance
- Quality control and quality assurance
- Pmp quality vs grade
- Pmp gold plating
- Quality assurance cycle in nursing
- Quality improvement vs quality assurance
- Basic concepts of quality assurance
- Healthcare and the healthcare team chapter 2
- Sports medicine definition
- Importance of quality control in pharmaceutical industry
- Cohort event monitoring
- Jamasoft
- Adrereport
- Medicine safety
- Pvnet pharmacovigilance
- Cem stands for in pharmacovigilance
- Lareb netherlands
- Solicited reports in pharmacovigilance
- Principles of pharmacovigilance
- What is pharmacovigilance
- International pharmacovigilance centre
- Pharmacovigilance signal detection methods
- Pharmacovigilance compliance
- Application of pharmacovigilance in zambia